CBD News‎ > ‎

CBD Daily NEWS

posted Apr 12, 2018, 3:44 AM by Scott Salisbury

Cannabidiol
Daily update  April 12, 2018
NEWS
Isodiol Featured on Global Cannabidiol Market Research
Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F) was recently featured on the Global Cannabidiol Market Research study as part of a report that traces “vital business parameters, technological innovations, mergers and acquisitions, Cannabidiol product launches and different business ...
Google PlusFacebookTwitterFlag as irrelevant
IDPH Posts RFP For Second Iowa Cannabidiol Manufacturer
The Iowa Department of Public Health (IDPH) has posted their second Request for Proposal (RFP) for a second medical cannabidiol manufacturer in the state. Interested parties must express their intent to apply by 4 p.m. on Wednesday, May 16. Formal applications must be turned in to the IDPH by ...
Google PlusFacebookTwitterFlag as irrelevant
Did the World Health Organization Declare Medical Marijuana Has No Health Risks?
The ECDD therefore concluded that current information does not justify scheduling of cannabidiol and postponed a fuller review of cannabidiol ... CBD safe has no legal bearing on its preparation and sale in the United States, and referred only to cannabidiol and not medical marijuana more broadly.
Google PlusFacebookTwitterFlag as irrelevant
Surge in sales of cannabidiol oil as Holland & Barrett becomes to first high street retailer to stock it
"We are constantly looking to bring new and innovative products to market that help our customers. "It is great to see in this instance that we can help with the demand." CBD (cannabidiol) is an active substance found in hemp oil which is taken from the leaves and flowers of hemp. It is legal as it has less ...
Google PlusFacebookTwitterFlag as irrelevant
Kickback Cold Brew Releases CBD-Infused Cold Brew Tea
LOS ANGELES — Kickback Cold Brew, a Los Angeles-based company, recently announced a new line of Cannabidiol (CBD) infused cold brew tea beverages for consumers. These new beverages will be immediately distributed to Southern California markets and are also available on their website.
Google PlusFacebookTwitterFlag as irrelevant
The Weed In Review
But the United Nations' World Health Organization (WHO) just announced it's launching a review of the international classification of cannabis, THC, cannabidiol, and other cannabis-related substances, and it wants feedback from its member nations. So Trump & Co. have opened their comments section ...
Google PlusFacebookTwitterFlag as irrelevant
Global Cannabidiol Oil (CBD Oil) Market Outlook 2018-2023 : ENDOCA, CBD American Shaman ...
Cannabidiol Oil (CBD Oil) Market The report on the global Cannabidiol Oil (CBD Oil) market offers complete data on the Cannabidiol Oil (CBD Oil) market. Elements such as main players, classification, size, environment of the business, SWOT analysis, and most effective trends in the market are ...
Google PlusFacebookTwitterFlag as irrelevant
Earth Science Tech Adds Pharmacist & LP3 as Chief of Pharmacy, Furthering Efforts to Obtain ...
DORAL, Florida, April 11, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields as well as on R&D for certain medical devices, is pleased to announce ...
Google PlusFacebookTwitterFlag as irrelevant
The First Hemp Company to Be Certified Kosher
GenCanna, which produces industrial hemp to form the bulk ingredient in lozenges, cannabidiol powder, tinctures and capsules, is based in Kentucky since the state classifies hemp as an agricultural product. Brett Goldman, the company's director of government and industry affairs, explains that, in the ...
Google PlusFacebookTwitterFlag as irrelevant
Bod Australia sets the stage for marketing medical cannabis oil in Australia
Bod also intends to put the cannabis oil through a clinical trial to remove any lingering doubts regarding the safety profile of cannabidiol (CBD) and its interaction with the human body. The upcoming phase 1 clinical trial is designed to test the safety, tolerability and pharmacokinetics of Linnea's unique ...
Google PlusFacebookTwitterFlag as irrelevant
Comments